327 related articles for article (PubMed ID: 9721036)
1. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.
Ben-Shabat S; Fride E; Sheskin T; Tamiri T; Rhee MH; Vogel Z; Bisogno T; De Petrocellis L; Di Marzo V; Mechoulam R
Eur J Pharmacol; 1998 Jul; 353(1):23-31. PubMed ID: 9721036
[TBL] [Abstract][Full Text] [Related]
2. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
Mechoulam R; Ben-Shabat S; Hanus L; Ligumsky M; Kaminski NE; Schatz AR; Gopher A; Almog S; Martin BR; Compton DR
Biochem Pharmacol; 1995 Jun; 50(1):83-90. PubMed ID: 7605349
[TBL] [Abstract][Full Text] [Related]
3. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
Lee M; Yang KH; Kaminski NE
J Pharmacol Exp Ther; 1995 Nov; 275(2):529-36. PubMed ID: 7473135
[TBL] [Abstract][Full Text] [Related]
4. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.
Ouyang Y; Hwang SG; Han SH; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):676-83. PubMed ID: 9547358
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of endogenous cannabinoids.
Martin BR; Mechoulam R; Razdan RK
Life Sci; 1999; 65(6-7):573-95. PubMed ID: 10462059
[TBL] [Abstract][Full Text] [Related]
7. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.
Panikashvili D; Simeonidou C; Ben-Shabat S; Hanus L; Breuer A; Mechoulam R; Shohami E
Nature; 2001 Oct; 413(6855):527-31. PubMed ID: 11586361
[TBL] [Abstract][Full Text] [Related]
8. Biochemistry of the endogenous ligands of cannabinoid receptors.
Di Marzo V; Deutsch DG
Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
[TBL] [Abstract][Full Text] [Related]
9. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.
Hanus L; Abu-Lafi S; Fride E; Breuer A; Vogel Z; Shalev DE; Kustanovich I; Mechoulam R
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3662-5. PubMed ID: 11259648
[TBL] [Abstract][Full Text] [Related]
10. 2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite.
Di Marzo V
Biochemistry (Mosc); 1998 Jan; 63(1):13-21. PubMed ID: 9526090
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid properties of methylfluorophosphonate analogs.
Martin BR; Beletskaya I; Patrick G; Jefferson R; Winckler R; Deutsch DG; Di Marzo V; Dasse O; Mahadevan A; Razdan RK
J Pharmacol Exp Ther; 2000 Sep; 294(3):1209-18. PubMed ID: 10945879
[TBL] [Abstract][Full Text] [Related]
12. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain.
Nakane S; Oka S; Arai S; Waku K; Ishima Y; Tokumura A; Sugiura T
Arch Biochem Biophys; 2002 Jun; 402(1):51-8. PubMed ID: 12051682
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
[TBL] [Abstract][Full Text] [Related]
14. Endogenous cannabinoid ligands--chemical and biological studies.
Mechoulam R; Ben Shabat S; Hanus L; Fride E; Vogel Z; Bayewitch M; Sulcova AE
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):45-9. PubMed ID: 8906544
[TBL] [Abstract][Full Text] [Related]
15. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
[TBL] [Abstract][Full Text] [Related]
16. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
17. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
Giuffrida A; Beltramo M; Piomelli D
J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
20. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]